Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Angela Maria Callari"'
Autor:
Paolo Tralongo, Nicolò Borsellino, Maria Lina Tirrito, Roberto Bordonaro, Vittorio Gebbia, Roberto Valenza, Francesco Verderame, Michele Caruso, F. Ferraù, Angela Maria Callari, Giuseppe Cicero
Publikováno v:
Annals of Oncology. 17:vii60-vii65
BACKGROUND: The aim of the study was to evaluate the safety and efficacy of the raltitrexed/5-fluorouracil/levofolinic acid combination regimen as first-line chemotherapy for elderly patients with advanced/metastatic colorectal cancer. PATIENTS AND M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3951193dd07c5431d06e92617146e4
https://doi.org/10.1093/annonc/mdl953
https://doi.org/10.1093/annonc/mdl953
Autor:
Calogero Cipolla, Nicola Gebbia, Cristina Garascia, Maria Pia Cusimano, Angela Maria Callari, Antonio Testa, G Cannata, Amato C, Mario Adelfio Latteri, Vittorio Gebbia, Biagio Agostara
Publikováno v:
Acta oncologica (Stockholm, Sweden). 33(8)
Thirty patients with measurable metastatic breast carcinoma were treated with a combination of cyclophosphamide 600 mg/m2 on day 1, levofolinic acid 100 mg/m2 plus 5-fluorouracil 375 mg/m2 on days 1-3, and epidoxorubicin (EDXR) in three refracted dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03e453782d9d01725ee5279876977fb6
https://pubmed.ncbi.nlm.nih.gov/7529516
https://pubmed.ncbi.nlm.nih.gov/7529516
Autor:
Biagio Agostara, Antonio Testa, Angela Maria Callari, Nicolo' Gebbia, Vittorio Gebbia, Maria Pia Cusimano
Publikováno v:
Scopus-Elsevier
Aims and background Patients with metastatic breast carcinoma resistant to first line chemotherapy may require further treatment. Results o second line chemotherapy are still largerly unsatisfactory. For this reason a phase II study on the combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557765db4f5341bb8515c2fabcc8b78a
http://www.scopus.com/inward/record.url?eid=2-s2.0-0028223643&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0028223643&partnerID=MN8TOARS
